InsidersTradesSigma
Follow the JCRファーマ株式会社 share price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are listed on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, JCRファーマ株式会社 has published 11 reports. Market capitalisation: €169.7bn. The latest transaction was disclosed on 20 February 2025 (Holding update). Among the most active insiders: Nomura Asset Management Co., Ltd.. The full history is free.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate JCRファーマ株式会社 Buy (bullish), based on 6 analysts. Average price target: JP¥4,833.
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,306 of 28,549 companies
65.6
score / 100
Value60
Quality72
FCF yld-4.2%
Earn yld8.1%
EV/EBITDA7.9x
ROE6.3%
Gross mgn47%
Net mgn14%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 February 2025
Declarations11 total
ShareXTKSEDINET:S100V9ZS
ShareXTKSEDINET:S100U2QJ
ShareXTKSEDINET:S100TAVB
ShareXTKSEDINET:S100SZZI
100.0% of flowShareXTKSEDINET:S100SBD8
ShareXTKSEDINET:S100RCJS
ShareXTKSEDINET:S100QJV3
0.0044% mcap21.8% of flowShareXTKSEDINET:S100QD5J
0.0046% mcap22.8% of flowShareXTKSEDINET:S100QA6Z
0.0057% mcap28.0% of flowShareXTKSEDINET:S100PYVH
0.0056% mcap27.4% of flowShareXTKSEDINET:S100PS4U
11 of 11 declarations
关于 JCRファーマ株式会社
JCR Pharma, Inc. 是一家专注于医疗保健和制药领域的公司。该公司在 XTKS 市场上市。